Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FWWD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,065
Award facts
- Contract value 100% obligated
- $15,065.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,065.02 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is set to complete by August 12, 2025, with performance to take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist primarily indicated for weight management in military and veteran populations, represents a critical pharmaceutical supply supporting Defense Health Agency operations.
This delivery order is executed under AmerisourceBergen's SPE2DX Pharmaceutical Prime Vendor Global contract, valued at $999,999,999, running through December 2026. The prime IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has demonstrated substantial capability in meeting federal procurement requirements through open competition, with an extensive portfolio of contract awards predominantly with the Defense Logistics Agency and its Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FWWD8?
SPE2DB25FWWD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FWWD8 worth?
The government has obligated $15,065 on SPE2DB25FWWD8.
Is contract SPE2DB25FWWD8 an order under another contract?
Yes. SPE2DB25FWWD8 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB25FWWD8 competed?
The extent of competition for SPE2DB25FWWD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award